Community/Retail

Carma Laboratories, Inc., the manufacturer of Carmex® lip balm products, is pleased to announce that its NEW Carmex® Cold Sore Treatment has been named the 2015 "Product of the Year" winner in the Specialty Skin Treatment category by Product of the Year USA " the nation's largest consumer survey on product innovation.

One in four acute ischemic stroke patients treated with a time-dependent clot-busting drug were quickly transferred from an emergency department or smaller community hospital to a certified stroke center.

The American Heart Association's Mission: Lifeline Program and Duke University's School of Medicine and School of Nursing announced today the receipt of a quality improvement grant of $3.5 million from the AstraZeneca Medical Education Grants Office to improve systems of care for quickly treating heart attacks.